Overview

An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabi

Status:
Completed

Trial end date:
2012-04-17

Target enrollment:

Participant gender:

Summary

An interaction study to assess the effect of the ezogabine/retigabine and the main metabolite NAMR on the pharmacokinetics of digoxin in healthy volunteers

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Digoxin
Ezogabine